This Hers review comes down to three numbers: 8.5 out of 10, our No. 3 score of 2026; $149 per month for the cheapest brand-name pill; and another $149 per month for the membership Hers requires before any medication ships. Hers has pivoted hard away from compounded semaglutide — which is not FDA-approved — and now leads with brand-name Wegovy, Ozempic, and Zepbound. The prices are genuinely competitive. The fine print is genuinely thick. Here is all of it, with the math done for you.
Hers in 60 Seconds
Hers is the women’s telehealth brand of Hims & Hers Health, Inc. (NYSE: HIMS), a platform operating since 2017. It runs weight-loss care in all 50 states, including Alaska and Hawaii, per Healthline reporting from March 2026. Visits are asynchronous — no video call in most states, no lab work required.
The 2026 medication menu is a brand-name lineup: the Wegovy pen and pill, Ozempic, Zepbound vials and KwikPens, and the Foundayo pill, priced from $149 to $299 per month. Compounded semaglutide, once the budget star at $199/mo, has been pushed to the margins. As of March 2026, Hers limits it to cases of medical necessity, and its prepaid compounded plans were discontinued per a July 2026 third-party review.
Say it plainly: compounded semaglutide was never FDA-approved. The FDA has published safety concerns about unapproved GLP-1 drugs, and it put Hers specifically on notice with a warning letter dated September 9, 2025. The pivot to brand names is the right move — it just came after the regulator knocked.
Hers Review Scorecard
| Fact | Detail |
|---|---|
| Our score | 8.5/10 — Very Good (No. 3 in our rankings) |
| Parent company | Hims & Hers Health, Inc. (NYSE: HIMS), platform since 2017 |
| Medications | Brand-name Wegovy, Ozempic, Zepbound, Foundayo; compounded only by medical necessity |
| Membership | $39 first month, then $149/mo, auto-renewing, billed separately |
| Cheapest med | From $149/mo (Wegovy pill, Ozempic pill, or Foundayo pill) |
| Insurance | No — cash pay only |
| Customer rating | ~3.8/5 across nearly 7,000 reviews, per Healthline (March 2026) |
| BBB | A+ rating |
| Regulatory record | FDA warning letter (Sept 9, 2025); Novo Nordisk lawsuit (Feb 9, 2026) |
| Coverage | All 50 states, incl. Alaska and Hawaii |
Why 8.5 and not higher? The A+ BBB grade, the $149 pill entry point, and 50-state reach are top-tier. The FDA letter, the Novo Nordisk lawsuit, zero insurance support, and a membership that guarantees nothing hold it out of the 8.8-and-up club.
Hers Cost Breakdown (2026)
Hers bills in two lanes: a required Weight Loss Membership and separately billed medication. Every medication price below comes from the official forhers.com drug-pricing page, fetched July 2026. All are cash prices, medication-only, and apply only if prescribed.
| Item | Price |
|---|---|
| Weight Loss Membership | $39 first month, then $149/mo, auto-renewing |
| Wegovy pill / Foundayo pill / Ozempic pill | From $149/mo |
| Wegovy pen / Ozempic injection | From $199/mo |
| Zepbound vial / Zepbound KwikPen | From $299/mo |
| Mounjaro / Zepbound (retail pens) | $1,899/mo |
| Generic liraglutide | $615/mo (per Healthline, March 2026) |
| Shipping | $5 per order (per third-party pricing reports) |
The spread is the sales pitch. Hers lists retail Zepbound and Mounjaro pens at $1,899/mo on the same page where its discounted formats start at $299/mo. That gap is real — brand GLP-1s cost four figures at a pharmacy counter without help, as our Wegovy cost without insurance guide breaks down in detail.
The $149 Membership That Guarantees Nothing
Here is the line most shoppers miss. The membership bills $39 for month one, then $149/mo, separately from medication — and the official site states it “does not include or guarantee a prescription.” You are paying $149 a month for access, messaging, and check-ins, not for medicine.
So run the real math. Cheapest first month: about $193 — $149 pill, $39 membership, $5 shipping, per third-party pricing reports checked July 9, 2026. Cheapest ongoing: about $303/mo. Choose a Zepbound format and the floor jumps to $448/mo ($299 + $149). Insurance cannot soften any of it, because Hers does not accept insurance.
From Prices Rise With Your Dose
Every medication price is a “from” price, and Hers does not publish full dose-by-dose pricing. Third-party reviewers note medication cost can vary by dose — and the FDA-approved Wegovy label titrates you upward over roughly 16 to 20 weeks. Treat $149 as the on-ramp, not the destination.
For context, the old model was different math entirely. Legacy compounded semaglutide ran $199/mo on a 6-month prepaid plan — $1,194 charged upfront — or $299 to $399 on monthly billing, per Healthline and GLP-1.com. Those prepaid plans are gone, and given that compounded semaglutide is not FDA-approved, we do not mourn them.
What Customers Complain About — and What They Praise
Start with the documented record. Hers holds a BBB A+ rating and averages about 3.8 out of 5 across nearly 7,000 customer reviews, per Healthline’s March 2026 reporting. That is a solid mid-tier score — stronger than most compounding-era rivals, softer than the A+ badge suggests on its own.
The complaint themes repeat across third-party review summaries: inconsistent shipping, slow customer service, and difficulty canceling subscriptions. The cancellation gripe has structural roots. Refunds apply only to initial orders canceled within 48 hours, shipped orders are non-refundable, and canceling medication does not cancel the $149/mo membership — partial-period membership refunds are generally not given, per third-party policy reviews.
Then there is the regulatory file, which is heavier than anything customers post. The FDA issued warning letter No. 716825 to Hims & Hers Health, Inc. dba Hers on September 9, 2025, citing false or misleading marketing of compounded semaglutide under FD&C Act sections 502(a) and 502(bb). A parallel letter hit the Hims brand, HIMS stock fell about 8% on the news per Seeking Alpha, and the letters were part of a wave of 55-plus FDA warning letters to compounded GLP-1 sellers announced September 16, 2025. Then Novo Nordisk sued Hims & Hers on February 9, 2026, alleging its compounded semaglutide products infringed U.S. Patent 8,129,343.
The praise is just as consistent. Reviewers highlight provider review within about 24 hours, no labs and no video visit in most states, useful app-based coaching tools, and 24/7 provider messaging. The platform is LegitScript certified, and the brand-name pivot means the product in the box is FDA-approved medication — at $149 to $299/mo against four-figure retail.
How Ordering From Hers Works
The process is fully online and takes five steps. Budget about a day for the medical review and a week for delivery.
Step 1: Sign up and verify. You create a profile on the website or app. A government ID is required, and you complete a medical intake questionnaire covering weight history, conditions, and medications.
Step 2: Provider review. A licensed provider reviews your intake asynchronously, typically within 24 hours, via messaging. No video visit is required in most states, and no lab work is required.
Step 3: Prescription — if appropriate. The provider decides whether to prescribe. Remember the fine print: the $149/mo membership does not guarantee a prescription, and you can be found ineligible after paying to start.
Step 4: Delivery. Medication ships to your door with $5 standard shipping. One catch per GLP-1.com: some GLP-1 injectables are not available in every state, so your menu may be shorter than the pricing page.
Step 5: Ongoing care. The membership covers provider messaging, check-ins, and dose titration as you step up. That is where the “from” pricing starts moving.
Set expectations from trials, not marketing. In the STEP 1 trial, adults on semaglutide 2.4 mg lost an average of 14.9% of body weight over 68 weeks. In SURMOUNT-1, tirzepatide delivered up to 20.9% over 72 weeks at the highest dose. Results vary person to person, and no platform — Hers included — can guarantee yours.
Hers vs Ro
Ro is our No. 1 pick at 8.8, and it runs the identical membership structure: $39 first month, then $149/mo. Both platforms make our 10 best weight loss meds ranking. They split on two things — insurance and regulatory record.
| Factor | Hers (8.5) | Ro (8.8) |
|---|---|---|
| Membership | $39 first month, then $149/mo | $39 first month, then $149/mo |
| Cheapest brand med | From $149/mo (pill formats) | $149 first month (pill formats) |
| Insurance | No — cash pay only | Yes — concierge files prior auths |
| BBB | A+ rating | B rating, 610 complaints |
| FDA record | Warning letter, Sept 9, 2025 | No warning letters found in our research |
| Lawsuits | Novo Nordisk suit, Feb 9, 2026 | None found in our research |
| Audience | Women-focused platform | General |
The decision rule is simple. Any realistic chance of insurance coverage? Ro wins — its concierge can shrink medication to a copay, which no amount of Hers pricing can match. Committed to cash pay and want a women-focused experience? Hers is competitive to the dollar, and its A+ BBB grade beats Ro’s B. If neither fits, Noom Med (8.7) splits the difference with medication plus structured behavior coaching.
Final Verdict: Who Should Actually Buy
Buy Hers if you are a cash-pay shopper who wants brand-name GLP-1s with minimal friction. The $149/mo pill entry, 24-hour asynchronous review, 50-state coverage, and A+ BBB rating make it the strongest women-focused option we rank. The brand-name pivot also means what arrives is FDA-approved medication — not a compounded product, which is never FDA-approved.
Skip Hers if you have insurance, hate subscriptions, or want a guarantee. There is no insurance billing, so your real floor is about $303/mo all-in. The membership auto-renews at $149/mo and, by the site’s own wording, does not guarantee a prescription. And the refund window is 48 hours on unshipped initial orders — that is it.
The Bottom Line of This Hers Review
Hers scores 8.5/10 — Very Good. It sells real, FDA-approved medication at honest cash prices, and it carries real baggage: a September 2025 FDA warning letter, a February 2026 Novo Nordisk lawsuit, and a $149/mo membership that guarantees nothing. Know all three numbers — $149 for the pill, $149 for the membership, 48 hours to change your mind — before you tap subscribe.